VORINOSTAT

VORINOSTAT was reported 2165 times

VORINOSTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIATION HEPATITIS 6 0.2222
1 OVARIAN EPITHELIAL CANCER STAGE III 2 0.1250
2 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
3 HEPATIC ARTERY FLOW DECREASED 1 0.1000
4 ANORECTAL INFECTION BACTERIAL 1 0.0667
5 RHINITIS ATROPHIC 2 0.0645
6 CHEMOTHERAPY CARDIOTOXICITY ATTENUATION 1 0.0625
7 FUNGAL TRACHEITIS 1 0.0625
8 LARYNGEAL CANCER METASTATIC 1 0.0476
9 LEPTOTRICHIA INFECTION 2 0.0444
10 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT 1 0.0385
11 CELLULITIS PHARYNGEAL 1 0.0323
12 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 2 0.0299
13 ACUTE MYELOID LEUKAEMIA REFRACTORY 5 0.0291
14 HEPATITIS B POSITIVE 1 0.0286
15 MYCOSIS FUNGOIDES 20 0.0243
16 SERRATIA TEST POSITIVE 2 0.0206
17 NEUROBLASTOMA RECURRENT 4 0.0197
18 MALIGNANT DYSPHAGIA 1 0.0175
19 ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 1 0.0164
20 STOMATOCOCCAL INFECTION 2 0.0161
21 ERYTHROLEUKAEMIA 1 0.0132
22 BRAIN STEM GLIOMA 2 0.0132
23 THYMUS ENLARGEMENT 2 0.0125
24 INFESTATION 3 0.0116
25 HYPERCALCAEMIA OF MALIGNANCY 3 0.0110
26 ELECTROCARDIOGRAM PQ INTERVAL PROLONGED 1 0.0108
27 VULVAL ULCERATION 3 0.0106
28 GINGIVAL CANCER 1 0.0104
29 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
30 LARYNGEAL HAEMORRHAGE 1 0.0087
31 JEJUNAL PERFORATION 2 0.0083
32 HEPATITIS C POSITIVE 1 0.0082
33 PSEUDOMONAL SEPSIS 14 0.0080
34 INCISION SITE DISCHARGE 2 0.0079
35 DENTAL PROSTHESIS USER 1 0.0079
36 INJECTION SITE MOVEMENT IMPAIRMENT 1 0.0078
37 HYPERVISCOSITY SYNDROME 2 0.0069
38 IMMUNOLOGY TEST ABNORMAL 1 0.0064
39 MONONEURITIS 1 0.0064
40 TUMOUR COMPRESSION 2 0.0063
41 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
42 SKIN FIBROSIS 3 0.0062
43 PARAKERATOSIS 2 0.0062
44 INTERNATIONAL NORMALISED RATIO 1 0.0062
45 VOCAL CORD DYSFUNCTION 3 0.0061
46 ANAPLASTIC ASTROCYTOMA 1 0.0061
47 HYPERCREATINAEMIA 2 0.0060
48 ANASTOMOTIC COMPLICATION 2 0.0058
49 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
50 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
51 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 2 0.0054
52 ACANTHOSIS NIGRICANS 1 0.0054
53 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 1 0.0053
54 T-CELL LYMPHOMA 6 0.0052
55 NEUROBLASTOMA 2 0.0052
56 HEPATITIS A ANTIBODY POSITIVE 1 0.0051
57 LIPOMATOSIS 1 0.0051
58 BRAIN TUMOUR OPERATION 1 0.0050
59 TRICHOSPORON INFECTION 2 0.0049
60 GRAM STAIN POSITIVE 1 0.0049
61 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
62 HEPATOBILIARY DISEASE 3 0.0048
63 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
64 MANTLE CELL LYMPHOMA RECURRENT 2 0.0046
65 HYPERMAGNESAEMIA 3 0.0046
66 CANDIDA SEPSIS 4 0.0045
67 MUCOCUTANEOUS ULCERATION 1 0.0044
68 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
69 ENTEROCOLITIS INFECTIOUS 4 0.0043
70 TORSADE DE POINTES 34 0.0043
71 LUNG ADENOCARCINOMA METASTATIC 1 0.0043
72 MENINGITIS FUNGAL 1 0.0043
73 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
74 MYELOID LEUKAEMIA 2 0.0040
75 ANORECTAL INFECTION 1 0.0040
76 BUDD-CHIARI SYNDROME 1 0.0040
77 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
78 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
79 CULTURE WOUND POSITIVE 1 0.0038
80 METAPNEUMOVIRUS INFECTION 3 0.0038
81 EMBOLISM 31 0.0037
82 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
83 STREPTOCOCCAL BACTERAEMIA 4 0.0037
84 COLON CANCER RECURRENT 1 0.0036
85 FEBRILE NEUTROPENIA 239 0.0036
86 INTRACRANIAL HAEMATOMA 2 0.0036
87 PAROTITIS 4 0.0034
88 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 8 0.0034
89 CATHETER SITE CELLULITIS 1 0.0034
90 HYPOPHOSPHATAEMIA 25 0.0034
91 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 2 0.0034
92 EPIPHYSES PREMATURE FUSION 1 0.0033
93 ENTEROCOLITIS VIRAL 1 0.0033
94 SOFT TISSUE INFECTION 6 0.0033
95 HEPATIC ISCHAEMIA 1 0.0032
96 LYMPHOCELE 2 0.0030
97 ESCHERICHIA BACTERAEMIA 7 0.0030
98 LYMPHOPENIA 42 0.0030
99 SOFT TISSUE NECROSIS 2 0.0029
100 BASAL GANGLIA INFARCTION 1 0.0029
101 ANASTOMOTIC LEAK 2 0.0029
102 ANION GAP DECREASED 1 0.0029
103 FUSARIUM INFECTION 2 0.0029
104 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 1 0.0028
105 NON-CARDIAC CHEST PAIN 9 0.0028
106 STEM CELL TRANSPLANT 7 0.0028
107 CARDIAC ENZYMES INCREASED 2 0.0028
108 HEART VALVE STENOSIS 1 0.0028
109 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
110 HEMIANOPIA HOMONYMOUS 2 0.0027
111 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
112 ALKALOSIS 1 0.0026
113 MALIGNANT ASCITES 2 0.0026
114 ADRENAL GLAND CANCER 1 0.0026
115 SYSTEMIC MYCOSIS 3 0.0026
116 ACUTE MYELOID LEUKAEMIA 40 0.0026
117 CHRONIC HEPATITIS C 1 0.0025
118 STREPTOCOCCAL SEPSIS 3 0.0025
119 SUPERINFECTION BACTERIAL 2 0.0025
120 URETERIC STENOSIS 2 0.0025
121 ECTHYMA 1 0.0025
122 LYMPHOCYTIC LEUKAEMIA 1 0.0025
123 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
124 CHLOROMA 1 0.0024
125 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
126 CORONA VIRUS INFECTION 1 0.0023
127 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
128 EOSINOPHILIC PNEUMONIA ACUTE 2 0.0023
129 CONGESTIVE HEPATOPATHY 1 0.0022
130 LYMPH GLAND INFECTION 1 0.0022
131 VASCULAR DEVICE INFECTION 10 0.0022
132 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
133 ADRENAL NEOPLASM 1 0.0021
134 DISSEMINATED ASPERGILLOSIS 1 0.0021
135 CELL MARKER INCREASED 1 0.0021
136 GASTROINTESTINAL TOXICITY 10 0.0021
137 TELANGIECTASIA 2 0.0021
138 MINIMAL RESIDUAL DISEASE 1 0.0021
139 ARTERIOVENOUS FISTULA 1 0.0020
140 BRAIN STEM STROKE 1 0.0020
141 METASTATIC SQUAMOUS CELL CARCINOMA 1 0.0020
142 FEMALE STERILISATION 1 0.0019
143 HYPERURICAEMIA 8 0.0019
144 BRUGADA SYNDROME 2 0.0019
145 ELECTROCARDIOGRAM QT PROLONGED 69 0.0019
146 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
147 FUNGAEMIA 3 0.0019
148 SYSTOLIC DYSFUNCTION 2 0.0019
149 TUMOUR NECROSIS 2 0.0019
150 COLON CANCER METASTATIC 3 0.0019
151 PNEUMONIA STREPTOCOCCAL 2 0.0018
152 PERIRECTAL ABSCESS 2 0.0018
153 LUNG INFECTION 28 0.0018
154 TROPONIN I INCREASED 3 0.0018
155 HAEMATOTOXICITY 17 0.0018
156 PNEUMONIA FUNGAL 7 0.0018
157 FEMALE GENITAL TRACT FISTULA 3 0.0018
158 PSEUDOMONAS INFECTION 15 0.0017
159 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
160 EYE ULCER 1 0.0017
161 ACUTE PRERENAL FAILURE 2 0.0017
162 TONGUE HAEMORRHAGE 2 0.0017
163 ACIDOSIS 13 0.0017
164 ENGRAFTMENT SYNDROME 1 0.0017
165 BONE MARROW TOXICITY 2 0.0017
166 FIBRIN D DIMER INCREASED 6 0.0017
167 NEUTROPENIC SEPSIS 12 0.0017
168 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
169 EMBOLISM VENOUS 5 0.0016
170 MUCOSAL INFLAMMATION 42 0.0016
171 ARTHRITIS REACTIVE 1 0.0016
172 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
173 HUMAN HERPESVIRUS 6 INFECTION 3 0.0016
174 POSTOPERATIVE WOUND COMPLICATION 2 0.0016
175 CHALAZION 1 0.0016
176 GLIOMA 1 0.0016
177 PLATELET TRANSFUSION 2 0.0016
178 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
179 GENE MUTATION 3 0.0015
180 ILEAL PERFORATION 1 0.0015
181 EMBOLIC CEREBRAL INFARCTION 1 0.0015
182 LEFT VENTRICULAR DYSFUNCTION 10 0.0015
183 CYSTITIS NONINFECTIVE 2 0.0015
184 INFECTIOUS PERITONITIS 1 0.0015
185 VIRAEMIA 2 0.0014
186 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
187 DEVICE RELATED INFECTION 22 0.0014
188 HYPOALBUMINAEMIA 11 0.0014
189 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
190 ENTEROCOLITIS 8 0.0014
191 MYELODYSPLASTIC SYNDROME 20 0.0014
192 CALCULUS URETERIC 1 0.0014
193 ADENOVIRUS INFECTION 4 0.0014
194 THROMBOCYTOPENIA 153 0.0014
195 DIFFERENTIATION SYNDROME 1 0.0014
196 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
197 HYPERBILIRUBINAEMIA 14 0.0014
198 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
199 SMALL CELL LUNG CANCER 2 0.0013
200 HYPOCALCAEMIA 25 0.0013
201 DIZZINESS EXERTIONAL 1 0.0013
202 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
203 LOCALISED OEDEMA 6 0.0013
204 CRITICAL ILLNESS 1 0.0013
205 NEUTROPHIL COUNT DECREASED 52 0.0013
206 VARICELLA 3 0.0013
207 PNEUMONIA VIRAL 4 0.0013
208 PNEUMONIA LEGIONELLA 2 0.0012
209 OPTIC NERVE DISORDER 2 0.0012
210 HERPES ZOSTER DISSEMINATED 1 0.0012
211 HEPATITIS VIRAL 1 0.0012
212 AORTIC VALVE DISEASE 2 0.0012
213 FUNGAL SEPSIS 1 0.0012
214 GASTROENTERITIS SALMONELLA 1 0.0012
215 GASTROINTESTINAL TUBE INSERTION 3 0.0012
216 GLIOBLASTOMA MULTIFORME 1 0.0012
217 LEUKAEMIA RECURRENT 2 0.0012
218 APLASTIC ANAEMIA 6 0.0011
219 EXTREMITY NECROSIS 2 0.0011
220 MELANOCYTIC NAEVUS 5 0.0011
221 ENTEROCUTANEOUS FISTULA 1 0.0011
222 HYPOKALAEMIA 52 0.0011
223 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
224 OPHTHALMIC HERPES ZOSTER 2 0.0011
225 BLOOD HIV RNA INCREASED 2 0.0011
226 BACTERAEMIA 13 0.0011
227 OPPORTUNISTIC INFECTION 2 0.0011
228 HAEMORRHAGE INTRACRANIAL 16 0.0011
229 HEPATIC CONGESTION 1 0.0011
230 KLEBSIELLA BACTERAEMIA 1 0.0011
231 TUMOUR HAEMORRHAGE 3 0.0011
232 ESCHERICHIA SEPSIS 3 0.0010
233 SINUS BRADYCARDIA 10 0.0010
234 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
235 PULMONARY HAEMORRHAGE 8 0.0010
236 LUNG INFILTRATION 9 0.0010
237 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
238 MUCOSAL DISORDER 1 0.0010
239 MESENTERIC VEIN THROMBOSIS 1 0.0010
240 HEPATITIS B 6 0.0010
241 SEPSIS 111 0.0010
242 PLATELET COUNT DECREASED 106 0.0010
243 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
244 DROWNING 1 0.0010
245 HYPERGLYCAEMIA 36 0.0010
246 BONE MARROW FAILURE 20 0.0010
247 DERMATITIS PSORIASIFORM 2 0.0010
248 SMALL INTESTINAL OBSTRUCTION 12 0.0010
249 GRAFT VERSUS HOST DISEASE 7 0.0010
250 LYMPHOCYTE COUNT DECREASED 17 0.0010
251 BLAST CELL COUNT INCREASED 1 0.0010
252 PNEUMONITIS 26 0.0010
253 HEPATITIS B REACTIVATION 3 0.0009
254 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
255 HYDROCEPHALUS 5 0.0009
256 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
257 PARESIS 2 0.0009
258 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
259 CARDIAC HYPERTROPHY 1 0.0009
260 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
261 HYPERCALCAEMIA 11 0.0009
262 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
263 KLEBSIELLA SEPSIS 1 0.0009
264 CLOSTRIDIAL INFECTION 3 0.0009
265 B-CELL LYMPHOMA 3 0.0009
266 HYPOXIA 31 0.0009
267 BRONCHOPNEUMONIA 3 0.0009
268 GRANULOMA 3 0.0009
269 FOLATE DEFICIENCY 1 0.0009
270 LUMBAR RADICULOPATHY 1 0.0009
271 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
272 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
273 NECROTISING FASCIITIS 3 0.0009
274 FEBRILE INFECTION 1 0.0008
275 PULSE ABSENT 4 0.0008
276 HAEMATOMA MUSCLE 1 0.0008
277 PYODERMA GANGRENOSUM 3 0.0008
278 RADIUS FRACTURE 2 0.0008
279 EMBOLISM ARTERIAL 1 0.0008
280 CANDIDA INFECTION 14 0.0008
281 ENTEROCOCCAL INFECTION 4 0.0008
282 BLOOD PHOSPHORUS DECREASED 3 0.0008
283 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
284 VENOOCCLUSIVE DISEASE 2 0.0008
285 AORTIC VALVE REPLACEMENT 1 0.0008
286 SYSTEMIC CANDIDA 2 0.0008
287 MALLORY-WEISS SYNDROME 1 0.0008
288 BLOOD BILIRUBIN ABNORMAL 1 0.0008
289 HEPATOSPLENOMEGALY 2 0.0008
290 CEREBRAL ISCHAEMIA 4 0.0008
291 ELECTROLYTE IMBALANCE 9 0.0008
292 RHINOVIRUS INFECTION 3 0.0008
293 FAILURE TO THRIVE 4 0.0008
294 SPINAL CORD COMPRESSION 3 0.0008
295 MUCORMYCOSIS 2 0.0008
296 ANAEMIA POSTOPERATIVE 1 0.0008
297 ASPERGILLOSIS 1 0.0008
298 DEHYDRATION 102 0.0008
299 VENOUS THROMBOSIS 3 0.0008
300 BLOOD ALBUMIN DECREASED 6 0.0008
301 GASTROENTERITIS NOROVIRUS 1 0.0008
302 INTESTINAL DILATATION 1 0.0007
303 HYPONATRAEMIA 42 0.0007
304 COLITIS 28 0.0007
305 CLUSTER HEADACHE 1 0.0007
306 PLEURITIC PAIN 2 0.0007
307 APPLICATION SITE INFLAMMATION 1 0.0007
308 CHOKING 14 0.0007
309 MALNUTRITION 8 0.0007
310 RESPIRATORY FAILURE 52 0.0007
311 ACUTE PULMONARY OEDEMA 4 0.0007
312 H1N1 INFLUENZA 1 0.0007
313 INTESTINAL FISTULA 1 0.0007
314 ANAEMIA 135 0.0007
315 PULMONARY TOXICITY 5 0.0007
316 SINUS TACHYCARDIA 10 0.0007
317 MENINGITIS BACTERIAL 1 0.0007
318 NEUTROPENIA 95 0.0007
319 ANOREXIA 9 0.0007
320 GASTRIC HAEMORRHAGE 8 0.0007
321 GALLBLADDER CANCER 1 0.0007
322 ABDOMINAL ABSCESS 3 0.0007
323 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
324 BRAIN HERNIATION 2 0.0007
325 BLOOD CULTURE POSITIVE 2 0.0007
326 MANTLE CELL LYMPHOMA 1 0.0007
327 BRAIN NEOPLASM 6 0.0007
328 CHRONIC MYELOID LEUKAEMIA 3 0.0006
329 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
330 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
331 CHOLANGITIS 4 0.0006
332 MULTIPLE MYELOMA 3 0.0006
333 BLOOD BLISTER 2 0.0006
334 LIMB DEFORMITY 1 0.0006
335 CYSTITIS INTERSTITIAL 1 0.0006
336 HERPES SIMPLEX 4 0.0006
337 BACTERIAL SEPSIS 2 0.0006
338 METASTASES TO LUNG 7 0.0006
339 ANTIBODY TEST POSITIVE 1 0.0006
340 HYPERNATRAEMIA 3 0.0006
341 FLUID INTAKE REDUCED 3 0.0006
342 DERMATITIS EXFOLIATIVE 3 0.0006
343 ENTEROBACTER INFECTION 1 0.0006
344 NEOPLASM RECURRENCE 2 0.0006
345 APPLICATION SITE DRYNESS 2 0.0006
346 ENTERITIS INFECTIOUS 1 0.0006
347 GLIOBLASTOMA 1 0.0006
348 BLOOD PH DECREASED 1 0.0006
349 RESPIRATORY ARREST 16 0.0006
350 ACUTE SINUSITIS 1 0.0006
351 SKIN NECROSIS 3 0.0006
352 TUMOUR LYSIS SYNDROME 5 0.0006
353 SUDDEN DEATH 6 0.0006
354 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
355 RENAL FAILURE ACUTE 24 0.0006
356 HISTOPLASMOSIS 1 0.0006
357 MONOPARESIS 1 0.0006
358 CONDUCTION DISORDER 1 0.0005
359 HYPERKERATOSIS 3 0.0005
360 LOBAR PNEUMONIA 1 0.0005
361 CARDIAC DYSFUNCTION 2 0.0005
362 PRODUCT USE IN UNAPPROVED INDICATION 133 0.0005
363 APPENDICITIS 5 0.0005
364 SKIN INFECTION 6 0.0005
365 PROTEIN TOTAL DECREASED 2 0.0005
366 INTERVERTEBRAL DISCITIS 1 0.0005
367 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
368 HERPES VIRUS INFECTION 3 0.0005
369 MULTI-ORGAN FAILURE 9 0.0005
370 PERICARDIAL EFFUSION 12 0.0005
371 MALIGNANT NEOPLASM PROGRESSION 53 0.0005
372 DISEASE PROGRESSION 61 0.0005
373 EARLY SATIETY 1 0.0005
374 HYPERTRIGLYCERIDAEMIA 3 0.0005
375 HYPOGEUSIA 1 0.0005
376 BICYTOPENIA 1 0.0005
377 COLOSTOMY 1 0.0005
378 NAIL DISCOLOURATION 2 0.0005
379 EMPYEMA 1 0.0005
380 ATRIAL FLUTTER 4 0.0005
381 BREAST DISORDER 1 0.0005
382 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
383 CHANGE OF BOWEL HABIT 1 0.0005
384 DIVERTICULAR PERFORATION 1 0.0005
385 CAPILLARY LEAK SYNDROME 1 0.0005
386 SOCIAL PROBLEM 2 0.0005
387 BLOOD BILIRUBIN INCREASED 13 0.0005
388 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
389 ATRIAL TACHYCARDIA 1 0.0005
390 BRAIN OEDEMA 6 0.0005
391 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
392 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
393 FEBRILE BONE MARROW APLASIA 2 0.0005
394 ENTERITIS 3 0.0005
395 FACIAL PALSY 1 0.0005
396 HEPATIC LESION 2 0.0005
397 PYELONEPHRITIS 4 0.0005
398 PLASMA CELL MYELOMA 18 0.0005
399 BLOOD CREATININE INCREASED 30 0.0005
400 CERVICAL DYSPLASIA 1 0.0005
401 BLOOD CREATINE INCREASED 2 0.0005
402 GASTROINTESTINAL ULCER 1 0.0005
403 BACTERIAL TEST POSITIVE 1 0.0004
404 PANCYTOPENIA 25 0.0004
405 HAEMOLYTIC ANAEMIA 4 0.0004
406 INTESTINAL PERFORATION 5 0.0004
407 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
408 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
409 EPISTAXIS 33 0.0004
410 HAEMATEMESIS 11 0.0004
411 SYNOVIAL CYST 2 0.0004
412 WHITE BLOOD CELL COUNT DECREASED 46 0.0004
413 VENTRICULAR TACHYCARDIA 7 0.0004
414 CARDIAC TAMPONADE 2 0.0004
415 METASTASIS 3 0.0004
416 EOSINOPHIL COUNT DECREASED 1 0.0004
417 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
418 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
419 NON-SMALL CELL LUNG CANCER 2 0.0004
420 HYPOVOLAEMIC SHOCK 2 0.0004
421 APHAGIA 2 0.0004
422 GASTROINTESTINAL OBSTRUCTION 1 0.0004
423 HUMERUS FRACTURE 2 0.0004
424 HEPATITIS C 5 0.0004
425 ATELECTASIS 4 0.0004
426 BREATH ODOUR 1 0.0004
427 HAEMATOLOGICAL INFECTION 1 0.0004
428 CYTOPENIA 5 0.0004
429 ENCEPHALOPATHY 10 0.0004
430 BREATH SOUNDS ABNORMAL 2 0.0004
431 STAPHYLOCOCCAL SEPSIS 2 0.0004
432 HYPERVOLAEMIA 2 0.0004
433 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
434 HYDRONEPHROSIS 3 0.0004
435 PULMONARY EMBOLISM 38 0.0004
436 CATHETER SITE HAEMORRHAGE 1 0.0004
437 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
438 KLEBSIELLA INFECTION 2 0.0004
439 ENDODONTIC PROCEDURE 1 0.0004
440 HAEMORRHAGE URINARY TRACT 1 0.0004
441 ILEOSTOMY 1 0.0004
442 CANCER PAIN 1 0.0004
443 ENDOCARDITIS 2 0.0004
444 PERIPHERAL VASCULAR DISORDER 2 0.0004
445 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
446 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
447 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
448 HERNIA REPAIR 1 0.0004
449 DEEP VEIN THROMBOSIS 25 0.0004
450 COMPARTMENT SYNDROME 1 0.0004
451 PARTIAL SEIZURES 2 0.0004
452 ORAL CANDIDIASIS 5 0.0004
453 BLOOD LACTIC ACID INCREASED 2 0.0004
454 TRICUSPID VALVE INCOMPETENCE 3 0.0004
455 NYSTAGMUS 2 0.0004
456 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
457 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
458 BLOOD SODIUM INCREASED 1 0.0004
459 HYPERKALAEMIA 13 0.0004
460 WOUND INFECTION 4 0.0004
461 ASPIRATION 4 0.0004
462 ESCHERICHIA INFECTION 3 0.0004
463 STAPHYLOCOCCAL INFECTION 12 0.0004
464 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
465 LEUKOPENIA 18 0.0004
466 SYNCOPE 36 0.0004
467 TRANSAMINASES INCREASED 8 0.0004
468 HYPOMAGNESAEMIA 5 0.0004
469 DIABETIC COMA 1 0.0004
470 NEPHROPATHY TOXIC 4 0.0004
471 BREAST CANCER STAGE IV 1 0.0004
472 GENERALISED ERYTHEMA 2 0.0004
473 SKIN HYPERPIGMENTATION 3 0.0003
474 BLOOD URIC ACID INCREASED 2 0.0003
475 GASTROINTESTINAL NECROSIS 1 0.0003
476 PLEURISY 2 0.0003
477 PULMONARY HYPERTENSION 7 0.0003
478 PRODUCT USE ISSUE 63 0.0003
479 HIV INFECTION 1 0.0003
480 CENTRAL VENOUS CATHETERISATION 1 0.0003
481 BONE MARROW DISORDER 1 0.0003
482 FUNGAL INFECTION 11 0.0003
483 NO THERAPEUTIC RESPONSE 4 0.0003
484 MASTICATION DISORDER 1 0.0003
485 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
486 FIBROSIS 1 0.0003
487 MENTAL STATUS CHANGES 9 0.0003
488 DIASTOLIC DYSFUNCTION 1 0.0003
489 DECREASED APPETITE 75 0.0003
490 EJECTION FRACTION DECREASED 5 0.0003
491 ERYTHEMA MULTIFORME 3 0.0003
492 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
493 FLANK PAIN 3 0.0003
494 INVESTIGATION 1 0.0003
495 EOSINOPHILIC PNEUMONIA 1 0.0003
496 BILE DUCT STONE 1 0.0003
497 CUSHINGOID 1 0.0003
498 HYPERCHOLESTEROLAEMIA 3 0.0003
499 HYPOVENTILATION 1 0.0003
500 LYMPHOCYTE COUNT INCREASED 1 0.0003
501 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
502 INFECTION 44 0.0003
503 CARDIAC ARREST 25 0.0003
504 APPETITE DISORDER 2 0.0003
505 CONVULSION 17 0.0003
506 BK VIRUS INFECTION 1 0.0003
507 METASTASES TO LYMPH NODES 2 0.0003
508 NEUROPATHY PERIPHERAL 28 0.0003
509 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
510 RESPIRATORY DISTRESS 8 0.0003
511 LARGE INTESTINE PERFORATION 2 0.0003
512 AORTIC STENOSIS 1 0.0003
513 EXTRASYSTOLES 2 0.0003
514 DYSGEUSIA 21 0.0003
515 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
516 HERPES ZOSTER 16 0.0003
517 BONE LESION 1 0.0003
518 OESOPHAGITIS 3 0.0003
519 HYPOMANIA 1 0.0003
520 AMYLASE INCREASED 1 0.0003
521 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
522 MEDICAL DEVICE COMPLICATION 2 0.0003
523 CEREBRAL DISORDER 2 0.0003
524 PULMONARY MASS 4 0.0003
525 LEUKOENCEPHALOPATHY 1 0.0003
526 HEPATIC FUNCTION ABNORMAL 10 0.0003
527 ATRIAL FIBRILLATION 26 0.0003
528 GENERAL SYMPTOM 2 0.0003
529 HEPATIC NECROSIS 1 0.0003
530 MITRAL VALVE INCOMPETENCE 3 0.0003
531 CATHETER SITE INFECTION 1 0.0003
532 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
533 CARDIO-RESPIRATORY ARREST 11 0.0003
534 PLEURAL EFFUSION 16 0.0003
535 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
536 LIPASE INCREASED 2 0.0003
537 GINGIVAL DISORDER 1 0.0003
538 PYREXIA 90 0.0003
539 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
540 DELIRIUM 9 0.0003
541 FAECES HARD 1 0.0003
542 EPIGASTRIC DISCOMFORT 1 0.0003
543 SKIN LESION 7 0.0003
544 ATAXIA 3 0.0003
545 PNEUMOTHORAX 4 0.0003
546 CHOLECYSTITIS 3 0.0003
547 ABSCESS 4 0.0003
548 CANDIDIASIS 1 0.0002
549 CYTOKINE RELEASE SYNDROME 5 0.0002
550 FULL BLOOD COUNT DECREASED 5 0.0002
551 ADRENAL INSUFFICIENCY 3 0.0002
552 APPLICATION SITE DISCOLOURATION 1 0.0002
553 HICCUPS 2 0.0002
554 APPLICATION SITE EXFOLIATION 1 0.0002
555 GASTROINTESTINAL PERFORATION 1 0.0002
556 SECOND PRIMARY MALIGNANCY 2 0.0002
557 VOMITING 113 0.0002
558 DERMATITIS 5 0.0002
559 CELLULITIS 12 0.0002
560 SKIN PLAQUE 2 0.0002
561 HEMIPARESIS 4 0.0002
562 BUNDLE BRANCH BLOCK LEFT 1 0.0002
563 AORTIC VALVE INCOMPETENCE 1 0.0002
564 PNEUMONIA 76 0.0002
565 ABSCESS LIMB 1 0.0002
566 FACIAL PARALYSIS 2 0.0002
567 LUNG NEOPLASM 1 0.0002
568 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
569 BLOOD POTASSIUM DECREASED 7 0.0002
570 BLOOD MAGNESIUM DECREASED 2 0.0002
571 SEPTIC SHOCK 10 0.0002
572 BLOOD CALCIUM INCREASED 2 0.0002
573 RASH MACULO-PAPULAR 5 0.0002
574 THROMBOSIS 18 0.0002
575 PULMONARY OEDEMA 10 0.0002
576 LEUKOCYTOSIS 4 0.0002
577 MUSCULAR WEAKNESS 25 0.0002
578 HYPOTENSION 44 0.0002
579 ABDOMINAL HERNIA 1 0.0002
580 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
581 PNEUMONIA BACTERIAL 2 0.0002
582 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
583 DIVERTICULITIS 6 0.0002
584 MASS 3 0.0002
585 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
586 BACTERIAL INFECTION 4 0.0002
587 STOMATITIS 13 0.0002
588 HAEMOGLOBIN DECREASED 22 0.0002
589 DIARRHOEA HAEMORRHAGIC 2 0.0002
590 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
591 LEUKAEMIA 2 0.0002
592 FRACTURE 4 0.0002
593 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
594 MEDICATION RESIDUE PRESENT 1 0.0002
595 LIVER FUNCTION TEST ABNORMAL 6 0.0002
596 GASTROENTERITIS 3 0.0002
597 HAEMORRHOIDS 4 0.0002
598 BONE PAIN 12 0.0002
599 HAEMATURIA 7 0.0002
600 HEPATOMEGALY 2 0.0002
601 RENAL FAILURE 27 0.0002
602 DIARRHOEA 130 0.0002
603 NEOPLASM PROGRESSION 7 0.0002
604 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
605 APPLICATION SITE SWELLING 1 0.0002
606 VAGINAL DISCHARGE 2 0.0002
607 AMMONIA INCREASED 1 0.0002
608 HYPOPHAGIA 5 0.0002
609 THERAPY CESSATION 10 0.0002
610 CACHEXIA 1 0.0002
611 MUSCULOSKELETAL CHEST PAIN 3 0.0002
612 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
613 ABDOMINAL PAIN 45 0.0002
614 TREATMENT FAILURE 16 0.0002
615 DELUSION 3 0.0002
616 BASAL CELL CARCINOMA 3 0.0002
617 PETECHIAE 2 0.0002
618 INTENTIONAL DRUG MISUSE 4 0.0002
619 RENAL IMPAIRMENT 16 0.0002
620 ULCER 3 0.0002
621 METABOLIC ACIDOSIS 6 0.0002
622 COMPRESSION FRACTURE 1 0.0002
623 WEIGHT DECREASED 52 0.0002
624 BREAST CANCER METASTATIC 2 0.0002
625 DYSPNOEA EXERTIONAL 7 0.0002
626 GINGIVITIS 1 0.0002
627 DECREASED ACTIVITY 2 0.0002
628 MELAENA 4 0.0002
629 INTESTINAL ISCHAEMIA 1 0.0002
630 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
631 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
632 HEART RATE ABNORMAL 1 0.0002
633 BLOOD UREA INCREASED 3 0.0002
634 ANGIOPATHY 1 0.0002
635 CHOLECYSTITIS ACUTE 1 0.0002
636 URINARY TRACT INFECTION 30 0.0002
637 ADVERSE EVENT 16 0.0002
638 CONFUSIONAL STATE 28 0.0002
639 METABOLIC DISORDER 1 0.0002
640 EYELID OEDEMA 2 0.0002
641 DECREASED INTEREST 1 0.0002
642 PSYCHOTIC DISORDER 5 0.0002
643 DRUG ERUPTION 3 0.0002
644 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
645 GALLBLADDER DISORDER 3 0.0002
646 THIRST 3 0.0002
647 APHASIA 5 0.0002
648 HYPOGLYCAEMIA 8 0.0002
649 BONE DISORDER 3 0.0002
650 SEIZURE 19 0.0002
651 DERMATITIS ACNEIFORM 1 0.0002
652 CARDIOMEGALY 2 0.0002
653 FATIGUE 126 0.0002
654 NAUSEA 128 0.0002
655 OSTEONECROSIS OF JAW 4 0.0002
656 HEPATIC STEATOSIS 3 0.0002
657 TOOTH EXTRACTION 2 0.0002
658 CONSTIPATION 35 0.0002
659 BLOOD SODIUM DECREASED 3 0.0002
660 CHOLESTASIS 3 0.0002
661 ACUTE RESPIRATORY FAILURE 3 0.0002
662 SKIN ULCER 4 0.0002
663 RASH GENERALISED 4 0.0002
664 APPLICATION SITE VESICLES 1 0.0002
665 RESPIRATORY TRACT INFECTION 4 0.0002
666 NODULE 2 0.0002
667 KIDNEY INFECTION 3 0.0002
668 ASPERGILLUS INFECTION 1 0.0002
669 HYPOGAMMAGLOBULINAEMIA 1 0.0002
670 GASTRITIS 4 0.0002
671 ACUTE KIDNEY INJURY 23 0.0002
672 VIRAL INFECTION 5 0.0002
673 URINARY RETENTION 5 0.0001
674 BODY TEMPERATURE INCREASED 3 0.0001
675 CROHN'S DISEASE 1 0.0001
676 ECCHYMOSIS 1 0.0001
677 CHILLS 17 0.0001
678 HYPERTRANSAMINASAEMIA 1 0.0001
679 HAEMORRHAGE 15 0.0001
680 SKIN REACTION 2 0.0001
681 DUODENAL ULCER 1 0.0001
682 LYMPHADENOPATHY 5 0.0001
683 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
684 SUBDURAL HAEMATOMA 2 0.0001
685 OEDEMA PERIPHERAL 17 0.0001
686 MYELOSUPPRESSION 5 0.0001
687 FLUID OVERLOAD 2 0.0001
688 DYSPHAGIA 13 0.0001
689 ACUTE MYOCARDIAL INFARCTION 4 0.0001
690 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
691 FEELING DRUNK 1 0.0001
692 RESPIRATORY DISORDER 4 0.0001
693 ADVERSE DRUG REACTION 12 0.0001
694 DYSARTHRIA 5 0.0001
695 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
696 OFF LABEL USE 115 0.0001
697 HYPERTHERMIA 1 0.0001
698 HAEMOLYSIS 1 0.0001
699 LYMPHOMA 2 0.0001
700 ATRIOVENTRICULAR BLOCK 1 0.0001
701 OEDEMA 7 0.0001
702 APNOEA 1 0.0001
703 THERAPY PARTIAL RESPONDER 2 0.0001
704 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
705 HAEMATOCHEZIA 7 0.0001
706 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
707 HYPOTHYROIDISM 4 0.0001
708 BLOOD DISORDER 1 0.0001
709 INTERSTITIAL LUNG DISEASE 6 0.0001
710 DYSPNOEA 70 0.0001
711 NEURALGIA 3 0.0001
712 CEREBRAL INFARCTION 3 0.0001
713 DECUBITUS ULCER 1 0.0001
714 ASPHYXIA 1 0.0001
715 METASTASES TO BONE 2 0.0001
716 DRUG LEVEL INCREASED 2 0.0001
717 PNEUMONIA ASPIRATION 3 0.0001
718 COAGULOPATHY 2 0.0001
719 EOSINOPHIL COUNT INCREASED 1 0.0001
720 SKIN DISORDER 4 0.0001
721 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
722 ABDOMINAL PAIN LOWER 3 0.0001
723 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
724 HAEMATOMA 3 0.0001
725 ORTHOSTATIC HYPOTENSION 2 0.0001
726 LOCAL SWELLING 2 0.0001
727 ANHEDONIA 3 0.0001
728 NEUROTOXICITY 2 0.0001
729 PANCREATITIS 6 0.0001
730 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
731 CARDIOTOXICITY 1 0.0001
732 CEREBRAL HAEMORRHAGE 4 0.0001
733 GASTROINTESTINAL INFECTION 1 0.0001
734 GOUT 2 0.0001
735 THERAPY NON-RESPONDER 5 0.0001
736 GASTROENTERITIS VIRAL 2 0.0001
737 C-REACTIVE PROTEIN INCREASED 4 0.0001
738 EXOSTOSIS 1 0.0001
739 DEATH 94 0.0001
740 HYPERTENSION 23 0.0001
741 GRAND MAL CONVULSION 1 0.0001
742 FEELING COLD 3 0.0001
743 HAEMOPTYSIS 3 0.0001
744 RENAL DISORDER 5 0.0001
745 HEPATIC ENCEPHALOPATHY 1 0.0001
746 LACERATION 1 0.0001
747 ARTERIOSCLEROSIS 1 0.0001
748 COMA 5 0.0001
749 ANGINA PECTORIS 3 0.0001
750 POST PROCEDURAL COMPLICATION 2 0.0001
751 AUTOIMMUNE DISORDER 1 0.0001
752 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
753 SKIN FISSURES 2 0.0001
754 ASCITES 3 0.0001
755 LABORATORY TEST ABNORMAL 3 0.0001
756 BODY TEMPERATURE DECREASED 1 0.0001
757 HYPOTONIA 1 0.0001
758 EMPHYSEMA 1 0.0001
759 CORONARY ARTERY DISEASE 3 0.0001
760 ASTHENIA 37 0.0001
761 TOOTH LOSS 2 0.0001
762 NERVOUS SYSTEM DISORDER 3 0.0001
763 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
764 SKIN EXFOLIATION 8 0.0001
765 INCONTINENCE 1 0.0001
766 EATING DISORDER 2 0.0001
767 FAECES DISCOLOURED 2 0.0001
768 MYOCARDIAL INFARCTION 16 0.0001
769 GASTROINTESTINAL PAIN 1 0.0001
770 INJECTION SITE NODULE 1 0.0001
771 APPLICATION SITE PAIN 2 0.0001
772 INFUSION RELATED REACTION 6 0.0001
773 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
774 GLOSSODYNIA 2 0.0001
775 FISTULA 1 0.0001
776 BLOOD CALCIUM DECREASED 1 0.0001
777 APPLICATION SITE PRURITUS 2 0.0001
778 CARDIAC FAILURE 7 0.0001
779 MUSCLE SPASMS 16 0.0001
780 LETHARGY 5 0.0001
781 DRY MOUTH 7 0.0001
782 HYPERLIPIDAEMIA 1 0.0001
783 TOXICITY TO VARIOUS AGENTS 14 0.0001
784 DRUG EFFECT INCOMPLETE 3 0.0001
785 PRESYNCOPE 2 0.0001
786 DYSURIA 3 0.0001
787 CYST 1 0.0001
788 ILEUS 1 0.0001
789 APPLICATION SITE IRRITATION 1 0.0001
790 TACHYCARDIA 7 0.0001
791 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
792 SINUSITIS 8 0.0001
793 UNRESPONSIVE TO STIMULI 2 0.0001
794 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
795 DEAFNESS 2 0.0001
796 ECZEMA 4 0.0001
797 APPLICATION SITE ERYTHEMA 2 0.0001
798 IMMUNE SYSTEM DISORDER 1 0.0001
799 BRADYCARDIA 4 0.0001
800 NEOPLASM MALIGNANT 5 0.0001
801 CARDIAC DISORDER 7 0.0001
802 MALIGNANT MELANOMA 1 0.0001
803 SOMNOLENCE 15 0.0001
804 FREQUENT BOWEL MOVEMENTS 2 0.0001
805 THROAT TIGHTNESS 2 0.0001
806 DRUG TOXICITY 1 0.0001
807 HEPATIC ENZYME INCREASED 5 0.0001
808 MOOD ALTERED 2 0.0001
809 GINGIVAL BLEEDING 1 0.0001
810 OSTEOPOROSIS 3 0.0001
811 DRUG INTOLERANCE 7 0.0001
812 NO ADVERSE EVENT 13 0.0001
813 APHONIA 1 0.0001
814 NECK PAIN 4 0.0001
815 ALOPECIA 14 0.0001
816 BLOOD TEST ABNORMAL 1 0.0001
817 BLINDNESS UNILATERAL 1 0.0001
818 DIALYSIS 1 0.0001
819 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
820 MENTAL DISORDER 3 0.0001
821 APATHY 1 0.0001
822 CHEST DISCOMFORT 7 0.0001
823 COUGH 19 0.0001
824 LIVER DISORDER 3 0.0001
825 COLON CANCER 1 0.0001
826 IMMUNODEFICIENCY 1 0.0001
827 ABDOMINAL DISTENSION 7 0.0001
828 HALLUCINATION 5 0.0001
829 HEPATIC FAILURE 2 0.0001
830 HYPOAESTHESIA ORAL 1 0.0001
831 NEPHROLITHIASIS 3 0.0001
832 COGNITIVE DISORDER 3 0.0001
833 MENINGIOMA 1 0.0001
834 HEAD INJURY 2 0.0001
835 DISEASE RECURRENCE 3 0.0001
836 DRUG INTERACTION 10 0.0001
837 CYSTITIS 2 0.0001
838 RASH ERYTHEMATOUS 3 0.0001
839 CONTUSION 6 0.0001
840 CARDIAC FAILURE CONGESTIVE 5 0.0001
841 DIZZINESS 31 0.0001
842 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
843 LUNG DISORDER 3 0.0001
844 OSTEONECROSIS 2 0.0001
845 DRUG DOSE OMISSION 10 0.0001
846 BLOOD PRESSURE DECREASED 4 0.0001
847 HYPOAESTHESIA 9 0.0001
848 RASH 26 0.0001
849 CHEST PAIN 11 0.0001
850 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
851 CEREBROVASCULAR ACCIDENT 10 0.0001
852 INJURY 4 0.0001
853 METASTASES TO LIVER 1 0.0001
854 COLD SWEAT 1 0.0001
855 PANIC ATTACK 2 0.0001
856 UNDERDOSE 4 0.0001
857 DRUG INEFFECTIVE 72 0.0001
858 BLOOD GLUCOSE ABNORMAL 1 0.0001
859 CONJUNCTIVITIS 1 0.0001
860 HEPATIC CIRRHOSIS 1 0.0001
861 BLOOD URINE PRESENT 1 0.0001
862 GASTRIC ULCER 1 0.0001
863 HOSPITALISATION 8 0.0001
864 LOWER LIMB FRACTURE 1 0.0001
865 BACK PAIN 12 0.0001
866 DYSPEPSIA 5 0.0001
867 DISABILITY 1 0.0001
868 HAEMATOCRIT DECREASED 1 0.0001
869 THERAPEUTIC RESPONSE DECREASED 3 0.0000
870 HEADACHE 31 0.0000
871 INFLUENZA LIKE ILLNESS 4 0.0000
872 POLLAKIURIA 2 0.0000
873 MALAISE 21 0.0000
874 LIVER FUNCTION TEST INCREASED 1 0.0000
875 RECTAL HAEMORRHAGE 2 0.0000
876 BALANCE DISORDER 4 0.0000
877 SWELLING FACE 3 0.0000
878 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
879 INTENTIONAL PRODUCT MISUSE 4 0.0000
880 DRY SKIN 6 0.0000
881 GASTROINTESTINAL DISORDER 4 0.0000
882 CHROMATURIA 1 0.0000
883 HEART RATE IRREGULAR 1 0.0000
884 ABDOMINAL PAIN UPPER 9 0.0000
885 SKIN IRRITATION 2 0.0000
886 INJECTION SITE REACTION 3 0.0000
887 SKIN DISCOLOURATION 2 0.0000
888 OROPHARYNGEAL PAIN 4 0.0000
889 HYPERSENSITIVITY 8 0.0000
890 BLOOD GLUCOSE INCREASED 8 0.0000
891 ARRHYTHMIA 2 0.0000
892 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
893 PRODUCTIVE COUGH 2 0.0000
894 GAIT DISTURBANCE 8 0.0000
895 DIABETIC KETOACIDOSIS 1 0.0000
896 MENTAL IMPAIRMENT 1 0.0000
897 PAIN 25 0.0000
898 BRONCHITIS 3 0.0000
899 ABASIA 1 0.0000
900 AGEUSIA 1 0.0000
901 UNEVALUABLE EVENT 3 0.0000
902 GASTRIC CANCER 1 0.0000
903 CARDIOVASCULAR DISORDER 1 0.0000
904 FALL 13 0.0000
905 PRURITUS 15 0.0000
906 LOSS OF CONSCIOUSNESS 5 0.0000
907 ERECTILE DYSFUNCTION 1 0.0000
908 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
909 SPEECH DISORDER 2 0.0000
910 BREAST CANCER FEMALE 1 0.0000
911 JAUNDICE 1 0.0000
912 LIMB INJURY 1 0.0000
913 TREATMENT NONCOMPLIANCE 2 0.0000
914 MEMORY IMPAIRMENT 5 0.0000
915 INFLUENZA 4 0.0000
916 MYALGIA 6 0.0000
917 DYSSTASIA 1 0.0000
918 DYSPHONIA 2 0.0000
919 ERYTHEMA 7 0.0000
920 LACRIMATION INCREASED 1 0.0000
921 DISCOMFORT 2 0.0000
922 EPILEPSY 1 0.0000
923 BLOOD PRESSURE INCREASED 5 0.0000
924 FEMUR FRACTURE 1 0.0000
925 DRUG-INDUCED LIVER INJURY 1 0.0000
926 RHINORRHOEA 2 0.0000
927 PRODUCT DOSE OMISSION 2 0.0000
928 CHOLELITHIASIS 1 0.0000
929 EYE DISORDER 1 0.0000
930 HEART RATE INCREASED 3 0.0000
931 GASTRIC DISORDER 1 0.0000
932 HEART RATE DECREASED 1 0.0000
933 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
934 ANXIETY 8 0.0000
935 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
936 CRYING 1 0.0000
937 ACCIDENTAL OVERDOSE 1 0.0000
938 EYE SWELLING 1 0.0000
939 INTESTINAL OBSTRUCTION 1 0.0000
940 DEPRESSION 6 0.0000
941 CONDITION AGGRAVATED 8 0.0000
942 DIABETES MELLITUS 2 0.0000
943 DISORIENTATION 1 0.0000
944 LUNG NEOPLASM MALIGNANT 1 0.0000
945 ABDOMINAL DISCOMFORT 4 0.0000
946 PAIN IN EXTREMITY 7 0.0000
947 PRODUCT STORAGE ERROR 2 0.0000
948 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
949 SUICIDAL IDEATION 2 0.0000
950 BLOOD CHOLESTEROL INCREASED 1 0.0000
951 DRY EYE 1 0.0000
952 FLUSHING 2 0.0000
953 PERIPHERAL SWELLING 3 0.0000
954 PARAESTHESIA 3 0.0000
955 DEPRESSED MOOD 1 0.0000
956 INSOMNIA 5 0.0000
957 OVERDOSE 4 0.0000
958 ANAPHYLACTIC REACTION 1 0.0000
959 ARTHROPATHY 1 0.0000
960 MEDICATION ERROR 1 0.0000
961 FLATULENCE 1 0.0000
962 CATARACT 1 0.0000
963 IRRITABILITY 1 0.0000
964 FEELING HOT 1 0.0000
965 VISUAL IMPAIRMENT 2 0.0000
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
967 MOBILITY DECREASED 1 0.0000
968 AGITATION 1 0.0000
969 PRODUCT DOSE OMISSION ISSUE 4 0.0000
970 WEIGHT INCREASED 3 0.0000
971 HOT FLUSH 1 0.0000
972 CHRONIC KIDNEY DISEASE 1 0.0000
973 INCORRECT DOSE ADMINISTERED 3 0.0000
974 ARTHRITIS 1 0.0000
975 FEELING ABNORMAL 3 0.0000
976 TREMOR 2 0.0000
977 ARTHRALGIA 5 0.0000
978 COMPLETED SUICIDE 1 0.0000
979 URTICARIA 2 0.0000
980 NASOPHARYNGITIS 2 0.0000
981 BREAST CANCER 1 0.0000
982 MIGRAINE 1 0.0000
983 ASTHMA 1 0.0000
984 EMOTIONAL DISTRESS 1 0.0000
985 HYPERHIDROSIS 1 0.0000
986 DRUG DEPENDENCE 1 0.0000
987 COVID-19 1 0.0000
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000